Literature DB >> 16934194

Current treatment of severe sepsis.

Ismail Cinel1, R Phillip Dellinger.   

Abstract

The treatment of severe sepsis includes three essential principles: eradication of the inciting infection using source control measures and empiric antibiotics, hemodynamic resuscitation of hypoperfusion to avoid acute life-threatening organ dysfunction, and sustained support of organ system dysfunction using interventions that minimize organ injury. Therapy can be divided into immediate steps taken to stabilize the patient, followed by more definitive therapeutic intervention. The evidence for best clinical practice for resuscitation, management of infection, and intensive care unit supportive care has recently been synthesized by the Surviving Sepsis Campaign and published as evidence-based guidelines for the management of severe sepsis and septic shock.

Entities:  

Year:  2006        PMID: 16934194     DOI: 10.1007/s11908-006-0046-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  61 in total

1.  Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis.

Authors:  D E Joyce; L Gelbert; A Ciaccia; B DeHoff; B W Grinnell
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

Review 2.  The impact of spontaneous breathing during mechanical ventilation.

Authors:  Christian Putensen; Thomas Muders; Dirk Varelmann; Hermann Wrigge
Journal:  Curr Opin Crit Care       Date:  2006-02       Impact factor: 3.687

3.  Early changes in organ function predict eventual survival in severe sepsis.

Authors:  Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

4.  Nitroglycerin in septic shock after intravascular volume resuscitation.

Authors:  Peter E Spronk; Can Ince; Martin J Gardien; Keshen R Mathura; Heleen M Oudemans-van Straaten; Durk F Zandstra
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 5.  Opening the microcirculation: can vasodilators be useful in sepsis?

Authors:  Mattijn Buwalda; Can Ince
Journal:  Intensive Care Med       Date:  2002-07-27       Impact factor: 17.440

6.  Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock.

Authors:  Yasser Sakr; Marc-Jacques Dubois; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598

7.  Intrapulmonary penetration of linezolid.

Authors:  David Honeybourne; Caroline Tobin; Gail Jevons; Jenny Andrews; Richard Wise
Journal:  J Antimicrob Chemother       Date:  2003-05-13       Impact factor: 5.790

8.  Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Authors:  Marin H Kollef; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2004-01-09       Impact factor: 17.440

9.  Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

Authors:  Jorge A Cepeda; Tony Whitehouse; Ben Cooper; Janeane Hails; Karen Jones; Felicia Kwaku; Lee Taylor; Samantha Hayman; Steven Shaw; Christopher Kibbler; Robert Shulman; Mervyn Singer; A Peter R Wilson
Journal:  J Antimicrob Chemother       Date:  2004-01-07       Impact factor: 5.790

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  5 in total

1.  A systemic treatment confronts a systemic disease.

Authors:  Lawrence E Hightower
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

2.  Accuracy of point of care ultrasound to identify the source of infection in septic patients: a prospective study.

Authors:  Francesca Cortellaro; Laura Ferrari; Francesco Molteni; Paolo Aseni; Marta Velati; Linda Guarnieri; Katia Barbara Cazzola; Silvia Colombo; Daniele Coen
Journal:  Intern Emerg Med       Date:  2016-05-28       Impact factor: 3.397

3.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

4.  Eritoran: the evidence of its therapeutic potential in sepsis.

Authors:  Shahzad G Raja; Gilles D Dreyfus
Journal:  Core Evid       Date:  2008-02-29

Review 5.  Severe sepsis and septic shock: management and performance improvement.

Authors:  Christa A Schorr; Sergio Zanotti; R Phillip Dellinger
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.